Nanotechnology for cancer treatment

Nanotechnology has the potential to increase the selectivity and potency of chemical, physical, and biological approaches for eliciting cancer cell death while minimizing collateral toxicity to nonmalignant cells. Materials on the nanoscale are increasingly being targeted to cancer cells with great...

Full description

Saved in:
Bibliographic Details
Published in:Nanotechnology reviews (Berlin) 2014-04, Vol.3 (2), p.111-122
Main Authors: Gmeiner, William H., Ghosh, Supratim
Format: Article
Language:English
Subjects:
Antigens
Behavior
Cancer
Cancer therapies
Carbon
Cell death
Clinical outcomes
Deoxyribonucleic acid
Disease
DNA
Drug delivery systems
drug-delivery
Efficiency
Epidermal growth factor
Grounds
Ligands
Materials selection
Medical imaging
Molecular weight
Mortality
Nanomaterials
Nanoparticles
Nanostructure
Nanotechnology
Permeability
Physiology
Polyethylene glycol
Proteins
Retention
Temperature
Toxicity
Viral infections
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Nanotechnology has the potential to increase the selectivity and potency of chemical, physical, and biological approaches for eliciting cancer cell death while minimizing collateral toxicity to nonmalignant cells. Materials on the nanoscale are increasingly being targeted to cancer cells with great specificity through both active and passive targeting. In this review, we summarize recent literature that has broken new ground in the use of nanotechnology for cancer treatment with an emphasis on targeted drug delivery.
ISSN:2191-9089
2191-9097
DOI:10.1515/ntrev-2013-0013